Supernus INDV
NASDAQ INDV
$36.25 +0.88 (+2.49%)
At close: Nov 2, 2026 · 4:00 PM EST

Supernus (INDV) EV to FCF (2024 - 2026)

Updated

Indivior Pharmaceuticals' EV to FCF came in at 126.64 for Q3 2026, up 487.5% from 21.56 a year earlier.

Analysis

Supernus (INDV) EV to FCF (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Indivior Pharmaceuticals reported EV to FCF of 107.54, up 839.5% year-over-year; for FY2024, it came in at 175.64.

  • Going back by year, EV to FCF was 4.04 in FY2021.
  • The Q3 2026 figure represents the highest quarterly EV to FCF since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Supernus 4.28 Bn 3.38 Bn 305.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 126.64
Sep 30, 2025 21.56
Jun 30, 2025 7.68
Mar 31, 2025 7.03
Dec 31, 2024 175.64
API Access

Supernus EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=INDV&period=max&api_key=YOUR_API_KEY